We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
-0.1%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$7.4B
AUM Growth
+$513M
Cap. Flow
+$604M
Cap. Flow %
8.16%
Top 10 Hldgs %
12.45%
Holding
1,816
New
83
Increased
1,274
Reduced
371
Closed
71

Top Buys

Rank Stock Value
1
SNN icon
Smith & Nephew
SNN
+$18.5M
2
PUK icon
Prudential
PUK
+$14.8M
3
DEO icon
Diageo
DEO
+$12.8M
4
AAPL icon
Apple
AAPL
+$10.3M
5
PG icon
Procter & Gamble
PG
+$9.59M

Top Sells

Rank Stock Value
1
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
+$16.5M
2
GSK icon
GSK
GSK
+$4.47M
3
GL icon
Globe Life
GL
+$3.21M
4
AGN
Allergan Inc
AGN
+$2.9M
5
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
+$2.28M

Sector Composition

Rank Sector Weight
1 Financials 16.89%
2 Technology 14.22%
3 Healthcare 14.03%
4 Energy 8.9%
5 Industrials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IO
1726
DELISTED
ION Geophysical Corporation
IO
$37K ﹤0.01%
886
-1,804
-67% -$96.5K
VTG
1727
DELISTED
VANTAGE DRILLING COMPANY ORD SHS (KY)
VTG
$37K ﹤0.01%
29,261
+18,754
+178% +$33.5K
ARRY
1728
DELISTED
Array Biopharma Inc
ARRY
$36K ﹤0.01%
+10,108
New +$39.8K
NTZ
1729
Natuzzi
NTZ
$14.9M
$34K ﹤0.01%
3,313
– –
RIC
1730
DELISTED
Richmont Mines Inc.
RIC
$32K ﹤0.01%
15,950
– –
ATHE
1731
Alterity Therapeutics
ATHE
$82.7M
$27K ﹤0.01%
208
-77
-27% -$10.3K
ACI
1732
DELISTED
ARCH COAL, INC.
ACI
$26K ﹤0.01%
1,216
-1,376
-53% -$41.2K
DNDN
1733
DELISTED
DENDREON CORPORATION
DNDN
$25K ﹤0.01%
17,390
-11,565
-40% -$20.3K
RTK
1734
DELISTED
Rentech, Inc.
RTK
$23K ﹤0.01%
+1,344
New +$29.2K
SVM
1735
Silvercorp Metals
SVM
$2.02B
$22K ﹤0.01%
13,743
-18,027
-57% -$33.1K
RXII
1736
DELISTED
GALENA BIOPHARMA INC COM
RXII
$21K ﹤0.01%
10,125
-1,119
-10% -$2.32K
OCLR
1737
DELISTED
Oclaro Inc.
OCLR
$15K ﹤0.01%
10,573
-1,117
-10% -$2.05K
IMMP
1738
Immutep
IMMP
$56.1M
$14K ﹤0.01%
4,133
– –
KWK
1739
DELISTED
QUICKSILVER RESOURCES INC
KWK
$13K ﹤0.01%
21,781
-14,396
-40% -$21.9K
AVEO
1740
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$12K ﹤0.01%
1,067
-292
-21% -$3.71K
BTM
1741
DELISTED
OI S.A. SPON ADR REPSTG 3 PFD SHS (BRA)
BTM
$12K ﹤0.01%
17,844
-4,255
-19% -$2.86K
GCVRZ
1742
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$6K ﹤0.01%
+13,212
New +$6.41K
AGIG
1743
Abundia Global Impact Group
AGIG
$40.5M
$4K ﹤0.01%
116
– –
CYHHZ
1744
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$1K ﹤0.01%
+18,332
New +$818
ARMK icon
1745
Aramark
ARMK
$15B
– –
-23,418
Closed -$438K
AVNT icon
1746
Avient
AVNT
$3.29B
– –
-5,415
Closed -$228K
CADE
1747
DELISTED
Cadence Bank
CADE
– –
-8,995
Closed -$221K
CTBI icon
1748
Community Trust Bancorp
CTBI
$1.42B
– –
-6,739
Closed -$231K
EDU icon
1749
New Oriental
EDU
$9.32B
– –
-8,226
Closed -$219K
ESGR
1750
DELISTED
Enstar Group
ESGR
– –
-1,366
Closed -$206K
68 69
70
71 72

Similar funds

OU
Optiver US Chicago, Illinois $50B AUM 53.51% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return

Aperio Group's Q3 2014 Portfolio in Review

As of Q3 2014, Aperio Group held 1,816 positions worth $7.4B, up 7.4% from $6.89B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Aperio Group deployed $604M of net new capital in Q3 2014, opening 83 new positions and adding to 1,274 existing holdings. Its largest new stake was Prudential: 326,014 shares worth $14.1M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was GSK, an estimated $4.47M trimmed.

  • Aperio Group's largest Q3 2014 buy was Prudential: 326,014 shares worth $14.1M.
  • Aperio Group added most to Smith & Nephew in Q3 2014, an estimated $18.5M increase.
  • Aperio Group's biggest Q3 2014 reduction was GSK, cutting an estimated $4.47M.
  • Aperio Group fully exited SIEMENS AKTIENGESELLSCHAFT ADS in Q3 2014, selling an estimated $16.5M.
  • Aperio Group's ten largest holdings make up 12% of its $7.4B portfolio in Q3 2014.
  • Aperio Group opened 83 new positions and closed 71 in Q3 2014.
  • Aperio Group's portfolio value rose 7.4% quarter-over-quarter to $7.4B.

Based on Aperio Group's 13F filing for Q3 2014, filed 21 Oct 2014.